tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HOWL Stock Latest News

Werewolf Therapeutics price target lowered to $7 from $8 at BofA
The FlyWerewolf Therapeutics price target lowered to $7 from $8 at BofA
19d ago
HOWL
Werewolf Therapeutics presents preclinical data on PREDATOR Platform
PremiumThe Fly
Werewolf Therapeutics presents preclinical data on PREDATOR Platform
30d ago
HOWL
Werewolf Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
Werewolf Therapeutics Reports Q3 2025 Financial Results
1M ago
HOWL
Werewolf Therapeutics reports Q3 EPS (36c), consensus (38c)
PremiumThe Fly
Werewolf Therapeutics reports Q3 EPS (36c), consensus (38c)
1M ago
HOWL
Werewolf Therapeutics’ WTX-330 Study: A Potential Game-Changer in Oncology
PremiumCompany Announcements
Werewolf Therapeutics’ WTX-330 Study: A Potential Game-Changer in Oncology
1M ago
HOWL
Werewolf Therapeutics’ Promising Study on WTX-124 in Cancer Treatment
PremiumCompany AnnouncementsWerewolf Therapeutics’ Promising Study on WTX-124 in Cancer Treatment
1M ago
HOWL
Werewolf Therapeutics receives FTD from U.S. FDA for WTX-124
Premium
The Fly
Werewolf Therapeutics receives FTD from U.S. FDA for WTX-124
2M ago
HOWL
Werewolf Therapeutics Faces Nasdaq Compliance Challenge
Premium
Company Announcements
Werewolf Therapeutics Faces Nasdaq Compliance Challenge
2M ago
8K
HOWL
Werewolf Therapeutics price target lowered to $8 from $9 at BofA
PremiumThe Fly
Werewolf Therapeutics price target lowered to $8 from $9 at BofA
3M ago
HOWL
Werewolf Therapeutics price target lowered to $3 from $4 at Citizens JMP
PremiumThe Fly
Werewolf Therapeutics price target lowered to $3 from $4 at Citizens JMP
4M ago
HOWL
Promising Advancements in Werewolf Therapeutics’ Drug Pipeline Support Buy Rating
PremiumRatings
Promising Advancements in Werewolf Therapeutics’ Drug Pipeline Support Buy Rating
4M ago
HOWL
Werewolf Therapeutics Faces Regulatory and Financial Challenges Amid FDA Disruptions
PremiumCompany Announcements
Werewolf Therapeutics Faces Regulatory and Financial Challenges Amid FDA Disruptions
4M ago
HOWL
Werewolf Therapeutics Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsWerewolf Therapeutics Reports Q2 2025 Financial Results
4M ago
HOWL
Werewolf Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Werewolf Therapeutics Reports Q2 2025 Financial Results
4M ago
8K
HOWL
Werewolf Therapeutics sees cash runway into 4Q26
Premium
The Fly
Werewolf Therapeutics sees cash runway into 4Q26
4M ago
HOWL
Werewolf Therapeutics reports Q2 EPS (40c), consensus (37c)
PremiumThe Fly
Werewolf Therapeutics reports Q2 EPS (40c), consensus (37c)
4M ago
HOWL
Werewolf Therapeutics Adopts New Bylaws and Elects Directors
PremiumCompany Announcements
Werewolf Therapeutics Adopts New Bylaws and Elects Directors
6M ago
8K
HOWL
Werewolf Therapeutics price target lowered to $9 from $10 at BofA
PremiumThe Fly
Werewolf Therapeutics price target lowered to $9 from $10 at BofA
6M ago
HOWL
Werewolf Therapeutics Receives Nasdaq Deficiency Notice
PremiumCompany Announcements
Werewolf Therapeutics Receives Nasdaq Deficiency Notice
7M ago
8K
HOWL
Strategic Expansion and Clinical Potential of Werewolf Therapeutics’ PREDATOR Platform Boosts Buy Rating
PremiumRatingsStrategic Expansion and Clinical Potential of Werewolf Therapeutics’ PREDATOR Platform Boosts Buy Rating
7M ago
HOWL
Werewolf Therapeutics price target lowered to $6 from $8 at Wedbush
Premium
The Fly
Werewolf Therapeutics price target lowered to $6 from $8 at Wedbush
7M ago
HOWL
Werewolf Therapeutics Reports Q1 2025 Financial Results
Premium
Company Announcements
Werewolf Therapeutics Reports Q1 2025 Financial Results
7M ago
HOWL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >